Personalized medicine partnership will focus on cancer and metabolic diseases.

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute, and Florida Hospital are collaborating to create a Personalized Medicine Partnership of Florida (PMP Florida). The aim is to accelerate discovery and development of new treatments in the areas of cancer and metabolic diseases.

The partnership will leverage Florida Hospital’s large patient population and clinical research expertise, Sanford-Burnham’s research expertise and technology platforms, and Moffitt’s biospecimen bank, data warehouse, and personalized medicine capabilities. One of the objectives of the partnership is to attract industry clients to utilize this resource.

PMP Florida will look to create alliances among Florida-based centers of excellence in medical research and clinical care. Together, the organizations will develop and utilize new molecular and genomic technologies to discover, translate, and personalize interventions for preventing and treating debilitating diseases.

It will try to mimick Moffitt’s Total Cancer Care™ to develop similar research and clinical protocols in other disease areas including metabolic diseases. Total Cancer Care is a treatment path that begins by mapping the more than 30,000 genes that make up a tumor to find its own unique genetic fingerprint.

Previous articleIllumina Shuns Roche’s $5.7 Bid, While Roche Prepares for the Long Haul
Next articleU.S. Drug Manufacturing Decline Reflects Wage Gap and Regulatory Scrutiny